When is transfer to an extracorporeal membrane oxygenation (ECMO) center indicated for the treatment of persistent pulmonary hypertension of the newborn (PPHN)?

Updated: Sep 03, 2019
  • Author: Kate A Tauber, MD; Chief Editor: Howard S Weber, MD, FSCAI  more...
  • Print


It is often difficult to determine the proper timing of a referral to an ECMO center. Referral and transfer should occur before refractory hypoxemia develops. Early consultation and discussion with clinicians at the ECMO center is strongly recommended.

Identifying and maintaining communication with clinicians at an ECMO center is especially important given the widespread availability of iNO therapy. Continuous delivery of iNO is required during transport. The referring center is responsible for determining what transport capabilities are available in order to administer a successful therapeutic iNO program.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!